Blood test aims to Fine-Tune heart risk management
NCT ID NCT04836117
First seen Apr 26, 2026 · Last updated May 13, 2026 · Updated 3 times
Summary
This study looked at whether a new blood test, called SomaSignal, could help doctors make better treatment decisions for people at higher risk of heart disease. The first 12 participants had their test results shared with their doctors to see if it led to changes in medications or lifestyle advice. The study was small and focused on testing the process, not on proving the test works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTH BEHAVIOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Intermountain Medical Center
Salt Lake City, Utah, 84107, United States
Conditions
Explore the condition pages connected to this study.